For men and women of child bearing potential: agreement to remain abstinent or use protocol defined contraceptive measures during the treatment period and for at least  months after the last dose of atezolizumab/placebo, or for at least  months after the last dose of paclitaxel
Agreement to remain abstinent or use adequate contraception, among women or men of childbearing potential
Willing to remain abstinent from consuming alcohol.
Agreement to remain abstinent or use adequate contraception, among women or men of childbearing potential
Willing to remain abstinent from consuming alcohol while on DSF
For women of childbearing potential: agreement to remain abstinent or use contraceptive methods
For women who are not postmenopausal (>=  months of non-therapy-induced amenorrhea) or surgically sterile (absence of ovaries and/or uterus): agreement to remain abstinent or use single or combined contraceptive methods as specified in protocol
For men: agreement to remain abstinent or use a condom plus an additional contraceptive method as specified in protocol
For women of childbearing potential: agreement to remain abstinent
For men: agreement to remain abstinent
Willing to remain abstinent from consuming alcohol while on disulfiram
For men receiving BCG: Agreement to remain abstinent (refrain from sexual intercourse) or use a condom
For women of childbearing potential: agreement to remain abstinent
Motivated to remain abstinent ( or higher out of )